this case report, a patient with massive pulmonary embolism (PE) confirmed by thorax computed tomography (CT) angiography was successfully treated with thrombolytic therapy. Massive PE can lead to cardiac arrest (CA) in 41% of patients, and the mortality rate was reported to be over 50% in patients with massive PE developing CA (2). We have several questions concerning the extrapolation of this case to a clinical setting. Because of the high mortality rate, appropriate risk stratification of high-risk patients is very important to reduce the mortality in such patients.
ischemic neurological sequelae may occur as a result of CA.
Second, in Baha et al.'s case, a varicose vein operation was associated with massive PE. However, the authors did not explain whether or not the patient had deep venous thrombus in the lower extremity preoperatively. Did the patient receive any anticoagulation therapy before the operation? When was the patient mobilized after surgery? If their patient had no additional risk factors, early mobilization may have been the only method for thromboprophylaxis in a low-risk procedure.
Third, Baha et al. did not describe the anesthesia that the patient received during the operation. Was the operation performed under local or general anesthesia? Marked increases have been observed postoperatively in the thrombotic factors causing a hypercoagulable and hypofibrinolytic state in patients receiving general anesthesia (5).
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